DEVELOP INTEGRATED DIAGNOSTIC BIOMARKERS OF ATHEROSCLEROSIS BASED ON EXPERIMENTAL STUDIES

Abstract

The study examined the effect of Biomaysa on the content of apoprotein in and total cholesterol, lipoprotein cholesterol and Lp FLA 2 in the dynamics of experimental hypercholesterolemia. Apoprotein B. of combined administration Biomaysa and ultroksa installed significant difference in the reduction of total cholesterol levels in ApoB 2.2 and 1.5, indicating good cholesterol reducing the effectiveness of the combination of these drugs by activating LDL receptor capture.